Midterm Results from the Prospective Multicenter Post Marketing Clinical Follow-up Study (PMCF) with Lifetech CeraFlex Occluder for Transcatheter Closure of Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), and Patent Ductus Arteriosus (PDA)

Background: The aim of this multicenter prospective study was to evaluate the safety, efficacy, procedural success, and short-term results of transcatheter closure of secundum type atrial septal defect (ASD), patent foramen ovale (PFO) and patent ductus arteriosus (PDA) with Lifetech CeraFlexTM occluders.